BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced.

Chang, XinyueXinyueChangSousa Augusto, Gilles AndersonGilles AndersonSousa AugustoLiu, XuelanXuelanLiuKündig, Thomas MThomas MKündigVogel, MoniqueMoniqueVogelMohsen, Mona Omar MahmoudMona Omar MahmoudMohsenBachmann, MartinMartinBachmann2024-10-072024-10-072021-09https://boris-portal.unibe.ch/handle/20.500.12422/59600enCOVID SARS-CoV vaccines600 - Technology::610 - Medicine & healthBNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced.article10.48350/1639003394895610.1111/all.14893